• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

123I-间碘苄胍在左右肝叶中的浓度。研究结果表明正常肝脏存在功能上的区域差异。

Concentration of 123I-metaiodobenzylguanidine in left and right liver lobes. Findings indicate regional differences in function in the normal liver.

作者信息

Jacobsson H, Johansson L, Kimiaei S, Larsson S A

机构信息

Department of Diagnostic Radiology, Karolinska Hospital, Stockholm, Sweden.

出版信息

Acta Radiol. 1999 Mar;40(2):224-8. doi: 10.3109/02841859909177744.

DOI:10.3109/02841859909177744
PMID:10080740
Abstract

PURPOSE

Normal radioactivity in the liver is often shown to be higher in the left lobe than in the right lobe at clinical examination by single photon emission computed tomography (SPECT) with 123I-metaiodobenzylguanidine (123I-MIBG). Our objective was to determine whether this represents a pathological condition.

MATERIAL AND METHODS

The distribution of 123I-MIBG in the liver was retrospectively studied in clinical patients who had normal CT examinations of the liver and spleen. In the SPECT sections of 27 123I-MIBG examinations, we determined the activity ratios between the left and right lobes. The control group comprised 33 examinations with (111)In-pentetreotide (OctreoScan) and 23 examinations with 99mTc-antigranulocyte antibody.

RESULTS

The mean activity ratio between left and right lobes for 123I-MIBG was 1.24, and for (111)In-pentetreotide 0.87. These figures differed significantly both from each other and from 1.00. The mean ratio for 99mTc-antibody at the early examinations was 0.99, and at the late examinations 0.95. These figures differed significantly from the values for 123I-MIBG and (111)In-pentetreotide.

CONCLUSION

The increased concentration of 123I-MIBG in the left lobe of the liver compared to the right lobe is a normal finding. The reason for this cannot be explained. The difference in the way in which the left and right lobes deal with the three radiopharmaceuticals is a new finding and indicates a regional difference in liver function that has not been reported previously.

摘要

目的

在临床检查中,通过单光子发射计算机断层扫描(SPECT)使用123I-间碘苄胍(123I-MIBG)时,肝脏的正常放射性通常显示左叶高于右叶。我们的目的是确定这是否代表一种病理状况。

材料与方法

回顾性研究了肝脏和脾脏CT检查正常的临床患者中123I-MIBG在肝脏中的分布情况。在27次123I-MIBG检查的SPECT切片中,我们确定了左右叶之间的活性比。对照组包括33次使用(111)In-奥曲肽(OctreoScan)的检查和23次使用99mTc-抗粒细胞抗体的检查。

结果

123I-MIBG左右叶的平均活性比为1.24,(111)In-奥曲肽为0.87。这些数值彼此之间以及与1.00均有显著差异。99mTc-抗体早期检查的平均比值为0.99,晚期检查为0.95。这些数值与123I-MIBG和(111)In-奥曲肽的值有显著差异。

结论

与右叶相比,肝脏左叶中123I-MIBG浓度增加是正常现象。其原因尚无法解释。左右叶处理这三种放射性药物方式的差异是一项新发现,表明肝脏功能存在尚未有报道的区域差异。

相似文献

1
Concentration of 123I-metaiodobenzylguanidine in left and right liver lobes. Findings indicate regional differences in function in the normal liver.123I-间碘苄胍在左右肝叶中的浓度。研究结果表明正常肝脏存在功能上的区域差异。
Acta Radiol. 1999 Mar;40(2):224-8. doi: 10.3109/02841859909177744.
2
Different concentrations of various radiopharmaceuticals in the two main liver lobes: a preliminary study in clinical patients.两种主要肝叶中不同浓度的各种放射性药物:临床患者的初步研究。
J Gastroenterol. 2005 Jul;40(7):733-8. doi: 10.1007/s00535-005-1617-9.
3
Different concentrations of I-123 MIBG and In-111 pentetreotide in the two main liver lobes in children: persisting regional functional differences after birth?儿童两个主要肝叶中不同浓度的I-123间碘苄胍和In-111喷替肽:出生后区域功能差异持续存在?
Clin Nucl Med. 2007 Jan;32(1):24-8. doi: 10.1097/01.rlu.0000249592.95945.e4.
4
111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma.111铟-喷替肽闪烁扫描术在化学感受器瘤的诊断和定位方面优于123碘-间碘苄胍闪烁扫描术。
Nucl Med Commun. 1998 Aug;19(8):735-42. doi: 10.1097/00006231-199808000-00003.
5
Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.十年间使用间碘苄胍(MIBG)的经验以及新型放射性标记肽的潜力:个人概述与总结
Q J Nucl Med. 1995 Dec;39(4 Suppl 1):150-5.
6
Clinical evaluation of no-carrier-added meta-[123I]iodobenzylguanidine for myocardial scintigraphy.无载体添加的间位-[123I]碘苄胍用于心肌闪烁显像的临床评估。
Eur J Nucl Med. 2000 Mar;27(3):302-7. doi: 10.1007/s002590050037.
7
Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.11C-间羟基麻黄碱全身PET/CT在交感神经系统肿瘤中的应用:可行性研究及与123I-MIBG SPECT/CT的比较
J Nucl Med. 2006 Oct;47(10):1635-42.
8
Improved labelling of no-carrier-added 123I-MIBG and preliminary clinical evaluation in patients with ventricular arrhythmias.
Nucl Med Commun. 1999 Jun;20(6):537-45. doi: 10.1097/00006231-199906000-00008.
9
Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy.致心律失常性右室心肌病的局部心肌交感神经去神经支配。一项使用123I-间碘苄胍闪烁显像的分析。
Circulation. 1994 Feb;89(2):667-83. doi: 10.1161/01.cir.89.2.667.
10
Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.生长抑素受体闪烁扫描术(锝[HYNIC,Tyr3]-奥曲肽)和123I-间碘苄胍闪烁扫描术在计算机断层扫描检测出的与SDHx基因相关的嗜铬细胞瘤和副神经节瘤患者中的应用价值
Neuroendocrinology. 2015;101(4):321-30. doi: 10.1159/000381458. Epub 2015 Mar 13.

引用本文的文献

1
Comprehensive analysis of [F]MFBG biodistribution normal patterns and variability in pediatric patients with neuroblastoma.神经母细胞瘤患儿中[F]MFBG生物分布正常模式及变异性的综合分析。
Eur J Nucl Med Mol Imaging. 2025 Aug 15. doi: 10.1007/s00259-025-07490-x.
2
Clinical value of I-metaiodobenzylguanidine single-photon emission computed tomography/computed tomography in spontaneous regression of localized congenital neuroblastoma: an evaluative study.间碘苄胍单光子发射计算机断层扫描/计算机断层扫描在局限性先天性神经母细胞瘤自发消退中的临床价值:一项评估研究
Quant Imaging Med Surg. 2025 Aug 1;15(8):6682-6691. doi: 10.21037/qims-2025-524. Epub 2025 Jul 17.
3
[F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [I] MIBG in neural crest tumour patients.
氟代间位碘代苄胍(F)MFBG PET 成像:在神经嵴肿瘤患者中的生物分布、药代动力学和与碘代间位碘代苄胍(I)MIBG 的比较。
Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1134-1145. doi: 10.1007/s00259-022-06046-7. Epub 2022 Nov 26.
4
I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis.碘代苄胍(MIBG)摄取的半定量 SPECT/CT 分析可预测神经母细胞瘤的早期复发。
Ann Nucl Med. 2021 May;35(5):549-556. doi: 10.1007/s12149-021-01595-7. Epub 2021 Feb 14.
5
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress.脂肪变性(NAFLD)和脂肪性肝炎(NASH)动物模型表现出肝叶特异性明胶酶活性和氧化应激。
Can J Gastroenterol Hepatol. 2019 Feb 3;2019:5413461. doi: 10.1155/2019/5413461. eCollection 2019.
6
Biodistribution and Dosimetry of F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies.氟代甲苄基胍的生物分布与剂量学:神经内分泌恶性肿瘤患者的首次人体 PET/CT 成像研究。
J Nucl Med. 2018 Jan;59(1):147-153. doi: 10.2967/jnumed.117.193169. Epub 2017 Jul 13.
7
Different concentrations of various radiopharmaceuticals in the two main liver lobes: a preliminary study in clinical patients.两种主要肝叶中不同浓度的各种放射性药物:临床患者的初步研究。
J Gastroenterol. 2005 Jul;40(7):733-8. doi: 10.1007/s00535-005-1617-9.